Celcuity (CELC) Amortization of Deferred Charges (2021 - 2025)
Celcuity (CELC) reported Amortization of Deferred Charges of $1.3 million for Q4 2025, up 402.37% on a YoY basis from $253000.0 in Q4 2024, and up 63.37% quarter-over-quarter from $778000.0 in Q3 2025.
Celcuity (CELC) Amortization of Deferred Charges (2021 - 2025) Analysis & Trends
Celcuity has reported Amortization of Deferred Charges for 5 years, with the latest figure at $1.3 million in Q4 2025.
- For the quarter ending Q4 2025, Amortization of Deferred Charges rose 402.37% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2025 stood at $3.1 million (up 129.99% YoY), and the FY2025 full-year result was $3.1 million, up 129.99% from the prior year.
- Amortization of Deferred Charges for Q4 2025 stood at $1.3 million, up from $778000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $1.3 million in Q4 2025, with the low at -$321966.0 in Q2 2023.
- Historically, Amortization of Deferred Charges has averaged $297607.7 across 5 years, with a median of $187820.0 in 2021.
- Annual changes were most pronounced in 2023 — Amortization of Deferred Charges tumbled 409.84% — and 2025, when it surged 402.37%.
- Celcuity's Amortization of Deferred Charges stood at $126640.0 in 2021, then slipped by 11.9% to $111573.0 in 2022, then plunged by 42.81% to $63813.0 in 2023, then surged by 296.47% to $253000.0 in 2024, then surged by 402.37% to $1.3 million in 2025.
- The last three Amortization of Deferred Charges figures came in at $1.3 million (Q4 2025), $778000.0 (Q3 2025), and $839000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.27 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 778,000.00 |
| Sep 30, 2025 | 778,000.00 |
| Jun 30, 2025 | 839,000.00 |
| Jun 30, 2025 | 839,000.00 |
| Mar 31, 2025 | 249,000.00 |
| Mar 31, 2025 | 249,000.00 |
| Dec 31, 2024 | 253,000.00 |
| Dec 31, 2024 | 253,000.00 |
| Sep 30, 2024 | 253,000.00 |
| Sep 30, 2024 | 253,000.00 |
| Jun 30, 2024 | 392,000.00 |
| Jun 30, 2024 | 392,000.00 |
| Mar 31, 2024 | 466,000.00 |
| Mar 31, 2024 | 466,000.00 |
| Dec 31, 2023 | 63,813.00 |
| Dec 31, 2023 | 63,813.00 |
| Sep 30, 2023 | 61,721.00 |
| Sep 30, 2023 | 61,721.00 |